Literature DB >> 20082468

MTHFR, TGFB3, and TGFA polymorphisms and their association with the risk of non-syndromic cleft lip and cleft palate in China.

JiangHui Zhu1, Ling Hao, Song Li, Lynn B Bailey, Yihua Tian, Zhu Li.   

Abstract

Our previous results indicated a moderate association between the methylenetetrahydrofolate reductase (MTHFR) gene 677C-T variant and an increased risk of non-syndromic cleft lip with or without cleft palate (nsCL/P) among the northern but not southern population in China, suggesting possible genetic heterogeneity in the etiology of nsCL/P between these two populations. It remains unknown whether the transforming growth factor alpha (TGFA) gene TaqI polymorphism and transforming growth factor beta 3 (TGFB3) gene CA repeats influence the risk of nsCL/P differently between the northern and southern Chinese populations. In this study of 188 Chinese case-parent triads, we found an independent association between the TGFB3 variant and risk of nsCL/P (OR = 2.10, 95% CI: 1.25-3.54 for heterozygotes; OR = 1.78, 95% CI: 0.83-3.83 for homozygotes). The MTHFR variant was associated with an increased risk of nsCL/P among children in the north (OR = 3.11, 95% CI: 1.18-8.23 for heterozygotes; OR = 3.36, 95%CI: 1.14-9.93 for homozygotes) and appear to interact marginally with the TGFB3 variant in the occurrence of nsCL/P among southern subjects (OR = 0.26, 95% CI: 0.06-1.07). No association was found between the TGFA variant and risk of nsCL/P in our data. Our results suggest that the TGFB3 gene variant may be an important genetic risk factor for nsCL/P occurrence in Chinese children, and we found no evidence of heterogeneity between northern and southern Chinese populations in the associations between TGFB3 and TGFA variants and risk of nsCL/P, but these results warrant further investigation. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082468     DOI: 10.1002/ajmg.a.33113

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Molecular Diagnostics and In Utero Therapeutics for Orofacial Clefts.

Authors:  J D Oliver; E C Turner; L R Halpern; S Jia; P Schneider; R N D'Souza
Journal:  J Dent Res       Date:  2020-07-01       Impact factor: 6.116

Review 2.  Genetics of nonsyndromic orofacial clefts.

Authors:  Fedik Rahimov; Astanand Jugessur; Jeffrey C Murray
Journal:  Cleft Palate Craniofac J       Date:  2011-05-05

3.  Intra-amniotic transient transduction of the periderm with a viral vector encoding TGFβ3 prevents cleft palate in Tgfβ3(-/-) mouse embryos.

Authors:  Chadwick Wu; Masa Endo; Byung H Yang; Melissa A Radecki; Patrick F Davis; Philip W Zoltick; Ryan M Spivak; Alan W Flake; Richard E Kirschner; Hyun-Duck Nah
Journal:  Mol Ther       Date:  2012-10-23       Impact factor: 11.454

4.  Association between Maternal MTHFR Polymorphisms and Nonsyndromic Cleft Lip with or without Cleft Palate in Offspring, A Meta-Analysis Based on 15 Case-Control Studies.

Authors:  Xinjuan Pan; Ping Wang; Xinjuan Yin; Xiaozhuan Liu; Di Li; Xing Li; Yongchao Wang; Hongle Li; Zengli Yu
Journal:  Int J Fertil Steril       Date:  2015-02-07

5.  Ras signaling and RREB1 are required for the dissociation of medial edge epithelial cells in murine palatogenesis.

Authors:  Toshihiro Inubushi; Ayaka Fujiwara; Takumi Hirose; Gozo Aoyama; Toshihiro Uchihashi; Naoki Yoshida; Yuki Shiraishi; Yu Usami; Hiroshi Kurosaka; Satoru Toyosawa; Susumu Tanaka; Tetsuro Watabe; Mikihiko Kogo; Takashi Yamashiro
Journal:  Dis Model Mech       Date:  2022-02-15       Impact factor: 5.758

6.  Association between polymorphism of TGFA Taq I and cleft lip and/or palate: a meta-analysis.

Authors:  Cuijuan Feng; Enjiao Zhang; Weiyi Duan; Zhongfei Xu; Yang Zhang; Li Lu
Journal:  BMC Oral Health       Date:  2014-07-11       Impact factor: 2.757

7.  Runx1-Stat3-Tgfb3 signaling network regulating the anterior palatal development.

Authors:  Safiye E Sarper; Hiroshi Kurosaka; Toshihiro Inubushi; Hitomi Ono Minagi; Koh-Ichi Kuremoto; Takayoshi Sakai; Ichiro Taniuchi; Takashi Yamashiro
Journal:  Sci Rep       Date:  2018-07-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.